Search

everythinglearnresearchcommunity

for

Search:↓

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Early diagnosis and personalized treatments are crucial for better hair loss management.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.